GEP20207076B - New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
GEP20207076B
GEP20207076B GEAP201614680A GEAP2016014680A GEP20207076B GE P20207076 B GEP20207076 B GE P20207076B GE AP201614680 A GEAP201614680 A GE AP201614680A GE AP2016014680 A GEAP2016014680 A GE AP2016014680A GE P20207076 B GEP20207076 B GE P20207076B
Authority
GE
Georgia
Prior art keywords
preparation
new
pharmaceutical compositions
compositions containing
hydroxyacid derivatives
Prior art date
Application number
GEAP201614680A
Other languages
English (en)
Inventor
Vernalis, (R&D) Ltd
Laboratoires Servier Les
Original Assignee
Vernalis R&D Ltd
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis R&D Ltd, Servier Lab filed Critical Vernalis R&D Ltd
Publication of GEP20207076B publication Critical patent/GEP20207076B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
GEAP201614680A 2015-06-23 2016-06-22 New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them GEP20207076B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1555753A FR3037958B1 (fr) 2015-06-23 2015-06-23 Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
GEP20207076B true GEP20207076B (en) 2020-03-10

Family

ID=54260902

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201614680A GEP20207076B (en) 2015-06-23 2016-06-22 New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them

Country Status (45)

Country Link
US (1) US10322131B2 (cg-RX-API-DMAC7.html)
EP (1) EP3313849B8 (cg-RX-API-DMAC7.html)
JP (1) JP6773695B2 (cg-RX-API-DMAC7.html)
KR (1) KR102620976B1 (cg-RX-API-DMAC7.html)
CN (1) CN107922432B (cg-RX-API-DMAC7.html)
AR (1) AR105104A1 (cg-RX-API-DMAC7.html)
AU (1) AU2016282827B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017027831A2 (cg-RX-API-DMAC7.html)
CA (1) CA2990083C (cg-RX-API-DMAC7.html)
CL (1) CL2017003316A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017012845A2 (cg-RX-API-DMAC7.html)
CU (1) CU20170162A7 (cg-RX-API-DMAC7.html)
DK (1) DK3313849T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2017000304A (cg-RX-API-DMAC7.html)
EA (1) EA036503B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP17082825A (cg-RX-API-DMAC7.html)
ES (1) ES2944942T3 (cg-RX-API-DMAC7.html)
FI (1) FI3313849T3 (cg-RX-API-DMAC7.html)
FR (1) FR3037958B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20207076B (cg-RX-API-DMAC7.html)
HK (1) HK1254477A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20230472T1 (cg-RX-API-DMAC7.html)
HU (1) HUE061758T2 (cg-RX-API-DMAC7.html)
IL (1) IL256320A (cg-RX-API-DMAC7.html)
JO (1) JO3807B1 (cg-RX-API-DMAC7.html)
LT (1) LT3313849T (cg-RX-API-DMAC7.html)
MA (1) MA42231B1 (cg-RX-API-DMAC7.html)
MD (1) MD3313849T2 (cg-RX-API-DMAC7.html)
MX (1) MX385720B (cg-RX-API-DMAC7.html)
MY (1) MY190243A (cg-RX-API-DMAC7.html)
PE (1) PE20180949A1 (cg-RX-API-DMAC7.html)
PH (1) PH12017502314B1 (cg-RX-API-DMAC7.html)
PL (1) PL3313849T3 (cg-RX-API-DMAC7.html)
PT (1) PT3313849T (cg-RX-API-DMAC7.html)
RS (1) RS64131B1 (cg-RX-API-DMAC7.html)
RU (1) RU2745430C9 (cg-RX-API-DMAC7.html)
SA (1) SA517390586B1 (cg-RX-API-DMAC7.html)
SI (1) SI3313849T1 (cg-RX-API-DMAC7.html)
SV (1) SV2017005590A (cg-RX-API-DMAC7.html)
TN (1) TN2017000529A1 (cg-RX-API-DMAC7.html)
TW (2) TW202108590A (cg-RX-API-DMAC7.html)
UA (1) UA124759C2 (cg-RX-API-DMAC7.html)
UY (1) UY36735A (cg-RX-API-DMAC7.html)
WO (1) WO2016207216A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201708626B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY37342A (es) 2016-07-22 2018-01-31 Servier Lab Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
WO2018126898A1 (zh) * 2017-01-05 2018-07-12 河南美泰宝生物制药有限公司 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用
BR112019013907A2 (pt) 2017-01-06 2020-02-04 Servier Lab combinação de um inibidor de mcl-1 e um composto de taxano, usos e composições farmacêuticas dos mesmos
UY37560A (es) * 2017-01-06 2018-07-31 Servier Lab Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
GEP20227357B (en) 2017-06-22 2022-02-25 Servier Lab Combination of mcl-1 inhibitor and standard of care treatment for hematologic cancers, uses and associated pharmaceutical compositions
KR20200041942A (ko) 2017-08-15 2020-04-22 애브비 인코포레이티드 거대환식 mcl-1 저해제 및 이의 용도
WO2019035914A1 (en) * 2017-08-15 2019-02-21 Abbvie Inc. MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
CN111372936B (zh) * 2017-11-23 2022-12-02 北京赛林泰医药技术有限公司 Mcl-1选择性抑制剂及其制备和用途
CN108424417B (zh) * 2017-12-21 2019-09-20 河南真实生物科技有限公司 噻吩并嘧啶衍生物、其制备方法及在制备抗肿瘤药物中的应用
AR116635A1 (es) 2018-10-15 2021-05-26 Servier Lab Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen
TWI849001B (zh) 2018-11-14 2024-07-21 法商施維雅藥廠 Mcl-1抑制劑及米哚妥林(midostaurin)之組合,其用途及醫藥組合物
AU2020279230A1 (en) * 2019-05-20 2021-12-02 Les Laboratoires Servier Mcl-1 inhibitor antibody-drug conjugates and methods of use
WO2020254299A1 (en) 2019-06-17 2020-12-24 Les Laboratoires Servier Combination of a mcl-1 inhibitor and a standard of care treatment for breast cancer, uses and pharmaceutical compositions thereof
CN113024577B (zh) * 2019-12-09 2023-06-30 首药控股(北京)股份有限公司 一种抗凋亡蛋白选择性抑制剂的制备方法
EP4251208A1 (en) 2020-11-24 2023-10-04 Novartis AG Mcl-1 inhibitor antibody-drug conjugates and methods of use
KR20240019283A (ko) 2021-06-11 2024-02-14 길리애드 사이언시즈, 인코포레이티드 Mcl-1 저해제와 항암제의 병용
CA3222752A1 (en) 2021-06-11 2022-12-15 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-body drug conjugates
AU2023272448A1 (en) 2022-05-20 2024-12-12 Les Laboratoires Servier Antibody-drug conjugates of antineoplastic compounds and methods of use thereof
WO2025111450A1 (en) 2023-11-22 2025-05-30 Les Laboratoires Servier Anti-cd74 antibody-drug conjugates and methods of use thereof
WO2025111431A1 (en) 2023-11-22 2025-05-30 Les Laboratoires Servier Anti-cd7 antibody-drug conjugates and methods of use thereof
TW202530255A (zh) 2023-12-15 2025-08-01 法商亞維西亞有限公司 抗il-1rap結合結構域及其抗體-藥物偶聯物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213305A1 (en) * 2005-11-02 2007-09-13 Cytovia, Inc. N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2008240188A1 (en) * 2007-04-13 2008-10-23 Supergen, Inc. Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
CN102464667B (zh) * 2010-11-03 2014-06-04 中国科学院上海药物研究所 一类五元杂环并嘧啶类化合物及其制备方法和用途
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3046792B1 (fr) * 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
WO2016207216A1 (en) 2016-12-29
TW201712019A (zh) 2017-04-01
UA124759C2 (uk) 2021-11-17
CA2990083C (en) 2021-05-25
US10322131B2 (en) 2019-06-18
CO2017012845A2 (es) 2018-03-28
PH12017502314A1 (en) 2018-06-25
RS64131B1 (sr) 2023-05-31
JO3807B1 (ar) 2021-01-31
HUE061758T2 (hu) 2023-08-28
DOP2017000304A (es) 2018-02-28
HRP20230472T1 (hr) 2023-07-21
NZ738469A (en) 2024-08-30
ECSP17082825A (es) 2018-02-28
TW202108590A (zh) 2021-03-01
PE20180949A1 (es) 2018-06-11
MY190243A (en) 2022-04-07
CN107922432A (zh) 2018-04-17
JP2018527296A (ja) 2018-09-20
SA517390586B1 (ar) 2022-02-20
SV2017005590A (es) 2018-06-01
BR112017027831A2 (pt) 2018-09-04
MX2017017008A (es) 2018-08-15
FR3037958A1 (cg-RX-API-DMAC7.html) 2016-12-30
EP3313849A1 (en) 2018-05-02
EP3313849B1 (en) 2023-02-22
AU2016282827A1 (en) 2018-01-18
PH12017502314B1 (en) 2018-06-25
ZA201708626B (en) 2022-06-29
FI3313849T3 (fi) 2023-05-11
DK3313849T3 (da) 2023-05-30
TWI715593B (zh) 2021-01-11
EP3313849B8 (en) 2023-05-10
HK1254477A1 (zh) 2019-07-19
UY36735A (es) 2016-12-30
LT3313849T (lt) 2023-05-10
PL3313849T3 (pl) 2023-07-10
MX385720B (es) 2025-03-18
EA201890124A1 (ru) 2018-05-31
CN107922432B (zh) 2021-05-04
JP6773695B2 (ja) 2020-10-21
KR20180015263A (ko) 2018-02-12
FR3037958B1 (fr) 2019-01-25
PT3313849T (pt) 2023-04-18
KR102620976B1 (ko) 2024-01-05
RU2745430C1 (ru) 2021-03-25
HK1250233A1 (zh) 2018-12-07
CU20170162A7 (es) 2018-06-05
TN2017000529A1 (en) 2019-04-12
ES2944942T3 (es) 2023-06-27
MA42231B1 (fr) 2023-04-28
SI3313849T1 (sl) 2023-07-31
AU2016282827B2 (en) 2020-07-09
MA42231A (fr) 2018-05-02
CA2990083A1 (en) 2016-12-29
RU2745430C9 (ru) 2021-06-28
IL256320A (en) 2018-02-28
CL2017003316A1 (es) 2018-04-27
EA036503B1 (ru) 2020-11-17
US20180185369A1 (en) 2018-07-05
AR105104A1 (es) 2017-09-06
MD3313849T2 (ro) 2023-07-31

Similar Documents

Publication Publication Date Title
GEP20207076B (en) New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them
GEP20207074B (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
IL256375B (en) History of new cyclics, process for their preparation and pharmaceutical preparations containing them
ZA201804770B (en) New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them
ZA201808286B (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
IL263463B (en) New piperidinyl compounds, a process for their preparation and pharmaceutical preparations containing them
IL254124A0 (en) New 3-indole-transformed histories, medicinal preparations and methods of use
IL260425B (en) New compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them